Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederendpoints.news
Endpoints News
Get the latest updates from Endpoints News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 30 days ago
Lawmakers urge appeals court to maintain halt on NIH's payment cut plan
30 days ago
A group of members of the House of Representatives told a federal...
Orphan drug, PBM changes fall out of Trump tax bill in Senate version
30 days ago
The Senate Finance Committee’s version of a massive tax cut package omits...
FDA approves CSL’s prophylactic for severe swelling condition
about 1 month ago
CSL Behring won FDA approval on Monday for its once-monthly preventive treatment...
FDA unveils pilot to speed some new drugs to market in just one month
about 1 month ago
A new FDA pilot program unveiled Tuesday aims to significantly cut drug...
AI biotech Xaira unveils virtual cell research paper
about 1 month ago
Last spring, Xaira Therapeutics launched with over a billion dollars, a star-studded...
Lyell’s lymphoma data for recently acquired CAR-T receive lukewarm reception on Wall Street
about 1 month ago
Lyell Immunopharma’s recently acquired CAR-T doesn't appear to impress Wall Street The...
Prothena moves forward with layoffs; Aldeyra resubmits dry eye drug to FDA
about 1 month ago
Plus, news about Ventyx Biosciences, Gilead Sciences, Insilico Medicine and Enliven Therapeutics...
Mineralys' lorundrostat gets a Phase 2 win in certain patients with hypertension
about 1 month ago
Mineralys Therapeutics said Tuesday that its blood pressure med lorundrostat has succeeded...
Dyne pivots on primary endpoint, delays filing for DM1 drug
about 1 month ago
Dyne Therapeutics met with the FDA to discuss what's needed for the...
Alphabet-backed Isomorphic Labs to open US office, hires ex-Relay CMO
about 1 month ago
Isomorphic Labs has hired its first chief medical officer to help establish...
Eli Lilly to buy gene editing biotech Verve Therapeutics for up to $1.3B
about 1 month ago
It appears that Eli Lilly couldn’t wait to get its hands on...
Immuneering reports Phase 2a MEK pill data in first-line pancreatic cancer
about 1 month ago
Immuneering’s oral MEK inhibitor allowed 94% of pancreatic cancer patients in a...